Developing a quality of life instrument in patients with psoriasis: The Psoriasis Quality of Life Questionnaire (PQLQ)

International Journal of Dermatology

Volumn 45, Issue 3, 2006, Pages 234-238

  Inanir, Işil ^a,b   Aydemir, Ömer ^a   Gündüz, Kamer ^a   Esen Danaci, Ayşen ^a   Türel, Aylin ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; EPIDEMIOLOGICAL DATA; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PSORIASIS; PSORIASIS SEVERITY INDEX; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; RELIGION; SCORING SYSTEM; SELF CONCEPT; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH STATUS INDICATORS; HUMANS; ISLAM; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STRESS, PSYCHOLOGICAL; TURKEY;

EID: 33644780841     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02448.x     Document Type: Article

References (29)

1. de Arruda LHF, de Moraes APF. The impact of psoriasis on quality of life. Br J Dermatol 2001; 144: 33-36.
2. McKenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996; 34: 534-538.
3. Ashroft DM, Po LW, Williams HC, et al. Quality of life measures in psoriasis: A critical appraisal of their quality. J Clin Pharm Ther 1998; 23: 391-398.
4. Rapp SR, Feldman SR, Exum ML. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1997; 41: 401-407.
5. Finlay AY, Khan GK, Luscombe DK, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990; 123: 751-756.
6. Kirby B, Richards HL, Hindle E, et al. Physical and psychological measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45: 72-76.
7. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195-201.
8. Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol 1993; 32: 587-591.
9. Scharloo M, Kaptein AA, Weinman J, et al. Patients' illness perceptions and coping as predictors of functional status in psoriasis: A 1 year follow-up. Br J Dermatol 2000; 142: 899-907.
10. Fortune DG, Richards HL, Main CJ. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998; 39: 196-201.
11. Fortune DG, Main CJ, Sullivan TM, et al. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-760.
12. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: A preliminary index of psoriasis-related stress. Acta Dermatol Venereol (Stockh) 1995; 75: 240-243.
13. Zachariae R, Zachariae H, Blomqvist K, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-1016.
14. Badia X, Mascaro JM, Lozano R. Measuring health related quality of life in patients with mild to moderate eczema and psoriasis: Clinical validity, reliability and sensitivity to change of the DLQI. Br J Dermatol 1999; 141: 698-702.
15. Root S, Kent G, al-Abadi MS. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189: 234-237.
16. Mombers FMC, de Korte J. A review of quality of life measurement in psoriasis. Br J Dermatol 1999; 141: 996-997.
17. Wahl A, Loge JH, Wicklund I, et al. The burden of psoriasis: A study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 2000; 43: 803-808.
18. Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis. Br J Dermatol 1999; 141: 1067-1075.
19. Kirby B, Fortune DG, Bhushan M, et al. The Salford Psoriasis Index: An holistic measure of psoriasis. Br J Dermatol 2000; 142: 728-732.
20. Baysal V, Yildirim M, Içke I, et al. The effect of psoriasis on quality of life. In: Utaş S, ed. 19th National Dermatology Congress (Nevşehir) Abstract Book, Vol. 63, 2002; 3-7.
21. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932; 140: 44-60.
22. Fredriksson T, Peterson UU. Severe psoriasis: Oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
23. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 22: 293-296.
24. Floyd FJ, Widaman KF. Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess 1995; 7: 286-299.
25. Anderson RT, Rajagopalan R. Development and validition of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41-50.
26. Morgan M, McCreedy R, Simpson J, et al. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202-206.
27. Finlay AY. Psoriasis from the patient's point of view. Arch Dermatol 2001; 137: 352-353.
28. Bullinger M, Anderson R, Cell AD. Developing and evaluating cross-cultural instruments: From minimal requirements to optimal models. Qual Life Res 1993; 2: 451-459.
29. Muldoon MF, Barger SD, Flory JD, et al. What are quality of life instruments measuring? Br Med J 1998; 316: 542-545.